![Development of effective anti-influenza drugs: congeners and conjugates – a review | Journal of Biomedical Science | Full Text Development of effective anti-influenza drugs: congeners and conjugates – a review | Journal of Biomedical Science | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12929-019-0567-0/MediaObjects/12929_2019_567_Fig4_HTML.png)
Development of effective anti-influenza drugs: congeners and conjugates – a review | Journal of Biomedical Science | Full Text
![The seafood Musculus senhousei shows anti-influenza A virus activity by targeting virion envelope lipids - ScienceDirect The seafood Musculus senhousei shows anti-influenza A virus activity by targeting virion envelope lipids - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006295220302100-ga1.jpg)
The seafood Musculus senhousei shows anti-influenza A virus activity by targeting virion envelope lipids - ScienceDirect
![Antiviral Drug -Oseltamivir (Anti-Influenza) = MOA in Animation + Online Test. GPAT-NIPER-Pharmacist - YouTube Antiviral Drug -Oseltamivir (Anti-Influenza) = MOA in Animation + Online Test. GPAT-NIPER-Pharmacist - YouTube](https://i.ytimg.com/vi/x9C-c2gHT1U/maxresdefault.jpg)
Antiviral Drug -Oseltamivir (Anti-Influenza) = MOA in Animation + Online Test. GPAT-NIPER-Pharmacist - YouTube
![Development of effective anti-influenza drugs: congeners and conjugates – a review | Journal of Biomedical Science | Full Text Development of effective anti-influenza drugs: congeners and conjugates – a review | Journal of Biomedical Science | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12929-019-0567-0/MediaObjects/12929_2019_567_Fig1_HTML.png)
Development of effective anti-influenza drugs: congeners and conjugates – a review | Journal of Biomedical Science | Full Text
![Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial - The Lancet Respiratory Medicine Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/56a392ee-a5d9-4484-89bc-94aae82353d1/gr1.gif)